Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design

Lisa Dixon, Gunvant Thaker, Robert Conley, David Ross, Nicola Cascella, Carol Tamminga

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

The goal of this study was to assess the time course of change in psychopathology and dyskinesia after neuroleptic withdrawal. Fifteen DSM-III schizophrenic patients were abruptly withdrawn in a double blind fashion from stable haloperidol treatment. Weekly ratings of dyskinesia and psychopathology were performed for 4 weeks post-withdrawal. There was an overall increase in dyskinesia ratings over the 4-week period (p<0.05) beginning in week 2, with dyskinetic movements of the fingers showing the most significant increase (p<0.0001). There were no overall changes in psychopathology, though the group appeared to be bimodal with 6 of the 15 patients showing a significant relapse in psychotic symptoms. Neither baseline TD nor psychotic relapse significantly interacted with change in TD over time. These schizophrenic patients showed an increase in global dyskinesia rating early within four weeks of neuroleptic withdrawal. This time course did not appear to be associated with reemergence of psychopathology which occured later. A significant minority of patients relapsed within this time period. This suggests the relative safety of brief periods of neuroleptic withdrawal for carefully selected patients in a controlled setting with specific goals (e.g., for evaluation or in preparation for clozapine) and the need to further understand who is at risk for rapid relapse.

Original languageEnglish (US)
Pages (from-to)267-271
Number of pages5
JournalSchizophrenia Research
Volume10
Issue number3
DOIs
StatePublished - 1993

Fingerprint

Dyskinesias
Psychopathology
Antipsychotic Agents
Recurrence
Clozapine
Haloperidol
Diagnostic and Statistical Manual of Mental Disorders
Fingers
Safety

Keywords

  • Dyskinesia
  • Neuroleptic withdrawal
  • Psychopathology

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Behavioral Neuroscience
  • Biological Psychiatry
  • Neurology
  • Psychology(all)

Cite this

Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design. / Dixon, Lisa; Thaker, Gunvant; Conley, Robert; Ross, David; Cascella, Nicola; Tamminga, Carol.

In: Schizophrenia Research, Vol. 10, No. 3, 1993, p. 267-271.

Research output: Contribution to journalArticle

Dixon, Lisa ; Thaker, Gunvant ; Conley, Robert ; Ross, David ; Cascella, Nicola ; Tamminga, Carol. / Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design. In: Schizophrenia Research. 1993 ; Vol. 10, No. 3. pp. 267-271.
@article{1d7500385b1b4d4fa34ea016acf78503,
title = "Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design",
abstract = "The goal of this study was to assess the time course of change in psychopathology and dyskinesia after neuroleptic withdrawal. Fifteen DSM-III schizophrenic patients were abruptly withdrawn in a double blind fashion from stable haloperidol treatment. Weekly ratings of dyskinesia and psychopathology were performed for 4 weeks post-withdrawal. There was an overall increase in dyskinesia ratings over the 4-week period (p<0.05) beginning in week 2, with dyskinetic movements of the fingers showing the most significant increase (p<0.0001). There were no overall changes in psychopathology, though the group appeared to be bimodal with 6 of the 15 patients showing a significant relapse in psychotic symptoms. Neither baseline TD nor psychotic relapse significantly interacted with change in TD over time. These schizophrenic patients showed an increase in global dyskinesia rating early within four weeks of neuroleptic withdrawal. This time course did not appear to be associated with reemergence of psychopathology which occured later. A significant minority of patients relapsed within this time period. This suggests the relative safety of brief periods of neuroleptic withdrawal for carefully selected patients in a controlled setting with specific goals (e.g., for evaluation or in preparation for clozapine) and the need to further understand who is at risk for rapid relapse.",
keywords = "Dyskinesia, Neuroleptic withdrawal, Psychopathology",
author = "Lisa Dixon and Gunvant Thaker and Robert Conley and David Ross and Nicola Cascella and Carol Tamminga",
year = "1993",
doi = "10.1016/0920-9964(93)90061-M",
language = "English (US)",
volume = "10",
pages = "267--271",
journal = "Schizophrenia Research",
issn = "0920-9964",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Changes in psychopathology and dyskinesia after neuroleptic withdrawal in a double-blind design

AU - Dixon, Lisa

AU - Thaker, Gunvant

AU - Conley, Robert

AU - Ross, David

AU - Cascella, Nicola

AU - Tamminga, Carol

PY - 1993

Y1 - 1993

N2 - The goal of this study was to assess the time course of change in psychopathology and dyskinesia after neuroleptic withdrawal. Fifteen DSM-III schizophrenic patients were abruptly withdrawn in a double blind fashion from stable haloperidol treatment. Weekly ratings of dyskinesia and psychopathology were performed for 4 weeks post-withdrawal. There was an overall increase in dyskinesia ratings over the 4-week period (p<0.05) beginning in week 2, with dyskinetic movements of the fingers showing the most significant increase (p<0.0001). There were no overall changes in psychopathology, though the group appeared to be bimodal with 6 of the 15 patients showing a significant relapse in psychotic symptoms. Neither baseline TD nor psychotic relapse significantly interacted with change in TD over time. These schizophrenic patients showed an increase in global dyskinesia rating early within four weeks of neuroleptic withdrawal. This time course did not appear to be associated with reemergence of psychopathology which occured later. A significant minority of patients relapsed within this time period. This suggests the relative safety of brief periods of neuroleptic withdrawal for carefully selected patients in a controlled setting with specific goals (e.g., for evaluation or in preparation for clozapine) and the need to further understand who is at risk for rapid relapse.

AB - The goal of this study was to assess the time course of change in psychopathology and dyskinesia after neuroleptic withdrawal. Fifteen DSM-III schizophrenic patients were abruptly withdrawn in a double blind fashion from stable haloperidol treatment. Weekly ratings of dyskinesia and psychopathology were performed for 4 weeks post-withdrawal. There was an overall increase in dyskinesia ratings over the 4-week period (p<0.05) beginning in week 2, with dyskinetic movements of the fingers showing the most significant increase (p<0.0001). There were no overall changes in psychopathology, though the group appeared to be bimodal with 6 of the 15 patients showing a significant relapse in psychotic symptoms. Neither baseline TD nor psychotic relapse significantly interacted with change in TD over time. These schizophrenic patients showed an increase in global dyskinesia rating early within four weeks of neuroleptic withdrawal. This time course did not appear to be associated with reemergence of psychopathology which occured later. A significant minority of patients relapsed within this time period. This suggests the relative safety of brief periods of neuroleptic withdrawal for carefully selected patients in a controlled setting with specific goals (e.g., for evaluation or in preparation for clozapine) and the need to further understand who is at risk for rapid relapse.

KW - Dyskinesia

KW - Neuroleptic withdrawal

KW - Psychopathology

UR - http://www.scopus.com/inward/record.url?scp=0027443030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027443030&partnerID=8YFLogxK

U2 - 10.1016/0920-9964(93)90061-M

DO - 10.1016/0920-9964(93)90061-M

M3 - Article

VL - 10

SP - 267

EP - 271

JO - Schizophrenia Research

JF - Schizophrenia Research

SN - 0920-9964

IS - 3

ER -